Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 793 to 799 of 799 entries
Sorted by: Best Match Show Resources per page
Synergistic combinations of clarithromycin with doxycycline or minocycline reduce the emergence of antimicrobial resistance in Rhodococcus equi.

Equine veterinary journal

Erol E, Shaffer CL, Lubbers BV.
PMID: 34480367
Equine Vet J. 2021 Sep 04; doi: 10.1111/evj.13508. Epub 2021 Sep 04.

BACKGROUND: The alarming increase in rifampin and macrolide resistance among Rhodococcus equi isolates highlights the need to identify alternative therapeutic options that can effectively control rhodococcosis in foals while limiting the further development of drug resistance.OBJECTIVES: To evaluate bacterial...

Cite
Erol E, Shaffer CL, Lubbers BV. Synergistic combinations of clarithromycin with doxycycline or minocycline reduce the emergence of antimicrobial resistance in Rhodococcus equi. Equine Vet J. 2021;doi: 10.1111/evj.13508.
Erol, E., Shaffer, C. L., & Lubbers, B. V. (2021). Synergistic combinations of clarithromycin with doxycycline or minocycline reduce the emergence of antimicrobial resistance in Rhodococcus equi. Equine veterinary journal, . https://doi.org/10.1111/evj.13508
Erol, Erdal, et al. "Synergistic combinations of clarithromycin with doxycycline or minocycline reduce the emergence of antimicrobial resistance in Rhodococcus equi." Equine veterinary journal vol. (2021). doi: https://doi.org/10.1111/evj.13508
Erol E, Shaffer CL, Lubbers BV. Synergistic combinations of clarithromycin with doxycycline or minocycline reduce the emergence of antimicrobial resistance in Rhodococcus equi. Equine Vet J. 2021 Sep 04; doi: 10.1111/evj.13508. Epub 2021 Sep 04. PMID: 34480367.
Copy Download .nbib Format: NLM
Sarecycline Treatment for Acne Vulgaris: Rationale for Weight-Based Dosing and Limited Impact of Food Intake on Clinical Efficacy.

Dermatologic therapy

Grada A, Del Rosso JQ, Graber E, Bunick CG, Stein Gold L, Moore AY, Baldwin H, Obagi Z, Damiani G, Carrothers T, McNamee B, Hanze E.
PMID: 34923732
Dermatol Ther. 2021 Dec 19;e15275. doi: 10.1111/dth.15275. Epub 2021 Dec 19.

Tetracycline-class antibiotics are frequently prescribed by dermatologists, commonly for acne vulgaris. Gastrointestinal absorption of first and second-generation tetracycline-class antibiotics, including doxycycline and minocycline, may be reduced by co-administration with food, resulting in potentially lower clinical efficacy. Development of novel...

Cite
Grada A, Del Rosso JQ, Graber E, et al. Sarecycline Treatment for Acne Vulgaris: Rationale for Weight-Based Dosing and Limited Impact of Food Intake on Clinical Efficacy. Dermatol Ther. 2021;e15275doi: 10.1111/dth.15275.
Grada, A., Del Rosso, J. Q., Graber, E., Bunick, C. G., Stein Gold, L., Moore, A. Y., Baldwin, H., Obagi, Z., Damiani, G., Carrothers, T., McNamee, B., & Hanze, E. (2021). Sarecycline Treatment for Acne Vulgaris: Rationale for Weight-Based Dosing and Limited Impact of Food Intake on Clinical Efficacy. Dermatologic therapy, e15275. https://doi.org/10.1111/dth.15275
Grada, Ayman, et al. "Sarecycline Treatment for Acne Vulgaris: Rationale for Weight-Based Dosing and Limited Impact of Food Intake on Clinical Efficacy." Dermatologic therapy vol. (2021): e15275. doi: https://doi.org/10.1111/dth.15275
Grada A, Del Rosso JQ, Graber E, Bunick CG, Stein Gold L, Moore AY, Baldwin H, Obagi Z, Damiani G, Carrothers T, McNamee B, Hanze E. Sarecycline Treatment for Acne Vulgaris: Rationale for Weight-Based Dosing and Limited Impact of Food Intake on Clinical Efficacy. Dermatol Ther. 2021 Dec 19;e15275. doi: 10.1111/dth.15275. Epub 2021 Dec 19. PMID: 34923732.
Copy Download .nbib Format: NLM
Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea.

The Journal of clinical and aesthetic dermatology

Stein Gold L, Del Rosso JQ, Kircik L, Bhatia ND, Hooper D, Nahm W, Stuart I.
PMID: 33282103
J Clin Aesthet Dermatol. 2020 Nov;13(11):44-49. Epub 2020 Nov 01.

No abstract available.

Cite
Stein Gold L, Del Rosso JQ, Kircik L, et al. Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea. J Clin Aesthet Dermatol. 2020;13(11):44-49
Stein Gold, L., Del Rosso, J. Q., Kircik, L., Bhatia, N. D., Hooper, D., Nahm, W., & Stuart, I. (2020). Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea. The Journal of clinical and aesthetic dermatology, 13(11), 44-49.
Stein Gold, Linda, et al. "Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea." The Journal of clinical and aesthetic dermatology vol. 13,11 (2020): 44-49.
Stein Gold L, Del Rosso JQ, Kircik L, Bhatia ND, Hooper D, Nahm W, Stuart I. Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea. J Clin Aesthet Dermatol. 2020 Nov;13(11):44-49. Epub 2020 Nov 01. PMID: 33282103; PMCID: PMC7716737.
Copy Download .nbib Format: NLM
Minocycline Mitigation of Tremor Syndrome and Defect of Cognitive and Balance Induced by Harmaline.

Basic and clinical neuroscience

Maneshian M, Nasirinezhad F, Mohammadi F, Behzadi M, Asadi-Shekaari M, Shabani M.
PMID: 34925722
Basic Clin Neurosci. 2021 Mar-Apr;12(2):255-268. doi: 10.32598/bcn.12.2.1980.1. Epub 2021 Mar 01.

INTRODUCTION: Minocycline has anti-inflammatory, anti-apoptotic, and anti-oxidant effects. Preclinical data suggest that minocycline could be beneficial for treating common neurological disorders, including Parkinson disease and multiple sclerosis.METHODS: In this study, the effects of minocycline on harmaline-induced motor and cognitive...

Cite
Maneshian M, Nasirinezhad F, Mohammadi F, et al. Minocycline Mitigation of Tremor Syndrome and Defect of Cognitive and Balance Induced by Harmaline. Basic Clin Neurosci. 2021;12(2):255-268doi: 10.32598/bcn.12.2.1980.1.
Maneshian, M., Nasirinezhad, F., Mohammadi, F., Behzadi, M., Asadi-Shekaari, M., & Shabani, M. (2021). Minocycline Mitigation of Tremor Syndrome and Defect of Cognitive and Balance Induced by Harmaline. Basic and clinical neuroscience, 12(2), 255-268. https://doi.org/10.32598/bcn.12.2.1980.1
Maneshian, Marzieh, et al. "Minocycline Mitigation of Tremor Syndrome and Defect of Cognitive and Balance Induced by Harmaline." Basic and clinical neuroscience vol. 12,2 (2021): 255-268. doi: https://doi.org/10.32598/bcn.12.2.1980.1
Maneshian M, Nasirinezhad F, Mohammadi F, Behzadi M, Asadi-Shekaari M, Shabani M. Minocycline Mitigation of Tremor Syndrome and Defect of Cognitive and Balance Induced by Harmaline. Basic Clin Neurosci. 2021 Mar-Apr;12(2):255-268. doi: 10.32598/bcn.12.2.1980.1. Epub 2021 Mar 01. PMID: 34925722; PMCID: PMC8672663.
Copy Download .nbib Format: NLM
Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions.

The Journal of clinical and aesthetic dermatology

Jones TM, Stuart I.
PMID: 33841618
J Clin Aesthet Dermatol. 2021 Mar;14(3):E53-E57. Epub 2021 Mar 01.

No abstract available.

Cite
Jones TM, Stuart I. Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions. J Clin Aesthet Dermatol. 2021;14(3):E53-E57
Jones, T. M., & Stuart, I. (2021). Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions. The Journal of clinical and aesthetic dermatology, 14(3), E53-E57.
Jones, Terry M, and Stuart, Iain. "Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions." The Journal of clinical and aesthetic dermatology vol. 14,3 (2021): E53-E57.
Jones TM, Stuart I. Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions. J Clin Aesthet Dermatol. 2021 Mar;14(3):E53-E57. Epub 2021 Mar 01. PMID: 33841618; PMCID: PMC8021408.
Copy Download .nbib Format: NLM
Type II minocycline-induced cutaneous and scleral hyperpigmentation.

Internal and emergency medicine

Min Z, Saini V, Mount CE, Bhanot N.
PMID: 34549380
Intern Emerg Med. 2021 Sep 21; doi: 10.1007/s11739-021-02853-2. Epub 2021 Sep 21.

No abstract available.

Cite
Min Z, Saini V, Mount CE, et al. Type II minocycline-induced cutaneous and scleral hyperpigmentation. Intern Emerg Med. 2021;doi: 10.1007/s11739-021-02853-2.
Min, Z., Saini, V., Mount, C. E., & Bhanot, N. (2021). Type II minocycline-induced cutaneous and scleral hyperpigmentation. Internal and emergency medicine, . https://doi.org/10.1007/s11739-021-02853-2
Min, Zaw, et al. "Type II minocycline-induced cutaneous and scleral hyperpigmentation." Internal and emergency medicine vol. (2021). doi: https://doi.org/10.1007/s11739-021-02853-2
Min Z, Saini V, Mount CE, Bhanot N. Type II minocycline-induced cutaneous and scleral hyperpigmentation. Intern Emerg Med. 2021 Sep 21; doi: 10.1007/s11739-021-02853-2. Epub 2021 Sep 21. PMID: 34549380.
Copy Download .nbib Format: NLM
Minocycline Attenuates Experimental Subarachnoid Hemorrhage in Rats.

Open life sciences

Li J, Chen S, Fan J, Zhang G, Ren R.
PMID: 33817197
Open Life Sci. 2019 Dec 31;14:595-602. doi: 10.1515/biol-2019-0067. eCollection 2019 Jan.

BACKGROUD: The aim of this study was to evaluate the therapeutic effect of minocycline on treating experimental subarachnoid hemorrhage (SAH) in rats and to explore its possible molecular mechanism.METHODS: SAH was induced in male Sprague-Dawley rats by endovascular perforation....

Cite
Li J, Chen S, Fan J, et al. Minocycline Attenuates Experimental Subarachnoid Hemorrhage in Rats. Open Life Sci. 2019;14:595-602doi: 10.1515/biol-2019-0067.
Li, J., Chen, S., Fan, J., Zhang, G., & Ren, R. (2019). Minocycline Attenuates Experimental Subarachnoid Hemorrhage in Rats. Open life sciences, 14595-602. https://doi.org/10.1515/biol-2019-0067
Li, Jingbo, et al. "Minocycline Attenuates Experimental Subarachnoid Hemorrhage in Rats." Open life sciences vol. 14 (2019): 595-602. doi: https://doi.org/10.1515/biol-2019-0067
Li J, Chen S, Fan J, Zhang G, Ren R. Minocycline Attenuates Experimental Subarachnoid Hemorrhage in Rats. Open Life Sci. 2019 Dec 31;14:595-602. doi: 10.1515/biol-2019-0067. eCollection 2019 Jan. PMID: 33817197; PMCID: PMC7874754.
Copy Download .nbib Format: NLM
Showing 793 to 799 of 799 entries